4//SEC Filing
Gallagher Brian M. Jr. 4
Accession 0000899243-17-019209
CIK 0001420565other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 6:27 PM ET
Size
5.7 KB
Accession
0000899243-17-019209
Insider Transaction Report
Form 4
Gallagher Brian M. Jr.
Director
Transactions
- Award
Stock Option (right to buy)
2017-07-25+20,000→ 20,000 totalExercise: $13.00Exp: 2027-07-24→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal annual installments over three years from July 25, 2017. The option was granted to the Reporting Person as director's compensation. As a Vice President at S.R. One, Limited and an employee of GlaxoSmithKline LLC, the Reporting Person is obligated to transfer any shares issued under the option to S.R. One, Limited, an indirect wholly-owned subsidiary of GlaxoSmithKline plc.
Documents
Issuer
AILERON THERAPEUTICS INC
CIK 0001420565
Entity typeother
Related Parties
1- filerCIK 0001709976
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 6:27 PM ET
- Size
- 5.7 KB